A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson’s disease
- 25 September 2003
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 184 (1) , 285-294
- https://doi.org/10.1016/s0014-4886(03)00250-4
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Phosphorylation of GluR4 AMPA‐type glutamate receptor subunit by protein kinase C in cultured retina amacrine neuronsEuropean Journal of Neuroscience, 2002
- Evaluation of [4‐O‐methyl‐11C]KW‐6002 as a potential PET ligand for mapping central adenosine A2A receptors in ratsSynapse, 2001
- LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa‐induced motor alterations in Parkinsonian ratsSynapse, 2001
- Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expressionJournal of Neurochemistry, 2001
- New Aspects of Physiological and Pathophysiological Functions of Adenosine A2AReceptor in Basal GangliaBioscience, Biotechnology, and Biochemistry, 2001
- Signal Transduction Mechanisms Involved in Ischemic Preconditioning in the Rat Retina in vivoExperimental Eye Research, 2000
- Driving AMPA Receptors into Synapses by LTP and CaMKII: Requirement for GluR1 and PDZ Domain InteractionScience, 2000
- A2 adenosine receptors: their presence and neuromodulatory role in the central nervous systemGeneral Pharmacology: The Vascular System, 1996
- Dual Signalling by the Adenosine A2a Receptor Involves Activation of Both N‐ and P‐Type Calcium Channels by Different G Proteins and Protein Kinases in the Same Striatal Nerve TerminalsJournal of Neurochemistry, 1996
- Characterization of Multiple Phosphorylation Sites on the AMPA Receptor GluR1 SubunitNeuron, 1996